David Wilder

Biography

Financial executive with extensive and broad industry experience in all aspects of corporate management. Both international and U.S. experience with a reputation for flexible approaches in varying operational environments, including underperforming and distressed situations. Proven track record of active and successful partnering with management team members to create a performance driven culture with enhanced operational effectiveness and financial awareness. 

Research Interest

Treatment of metabolic diseases, developing new medicines and technologies, immune modulating small molecule, cell therapy based artificial pancreas for the treatment of type 1 diabetes, PCR based molecular diagnostic measuring hypomethylated beta cell-derived DNA as a biomarker of beta cell loss for the early detection of the onset of type 1 diabetes or insulin dependent type 2 diabetes